Roger Bolsöy
Profile
Roger Bolsöy is the founder of Intrance Medical Systems, Inc. which was founded in 2018.
He previously worked as Head-Production at NeoPharma AB.
Former positions of Roger Bolsöy
| Companies | Position | End |
|---|---|---|
Intrance Medical Systems, Inc.
 Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Founder | - |
NeoPharma AB /Old/
 NeoPharma AB /Old/ Pharmaceuticals: MajorHealth Technology NeoPharma AB developed, manufactured and marketed patent-protected pharmaceutical formulations and systems for the treatment of Parkinson's disease. It provided medicines, administration and information systems for patients and health economy of society. The company was headquartered in Uppsala, Sweden | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
NeoPharma AB /Old/
NeoPharma AB /Old/ Pharmaceuticals: MajorHealth Technology NeoPharma AB developed, manufactured and marketed patent-protected pharmaceutical formulations and systems for the treatment of Parkinson's disease. It provided medicines, administration and information systems for patients and health economy of society. The company was headquartered in Uppsala, Sweden | Health Technology |
Intrance Medical Systems, Inc.
Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Health Technology |
- Stock Market
- Insiders
- Roger Bolsöy
